Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
英国2型糖尿病患者开始使用GLP-1受体激动剂治疗的时机
期刊:Drugs in Research & Development
影响因子:2.1
doi:10.1007/s40268-019-0273-0
Boye, Kristina S; Stein, Dara; Matza, Louis S; Jordan, Jessica; Yu, Ren; Norrbacka, Kirsi; Hassan, Syed Wasi; García-Pérez, Luis-Emilio
